Experts Debate if M&A is Exit or Financing Strategy
SAN DIEGO – Given the steep decline in third quarter biotech fundraising – down 48 percent from the same period last year – it's no surprise that companies are looking for alternatives. And at the recent Foley & Lardner Life Sciences conference in San Diego, a panel debated the merits of considering mergers and acquisitions as a financing strategy rather than an exit strategy.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter